Co-Authors
This is a "connection" page, showing publications co-authored by Paolo Cameli and Bruno Frediani.
Connection Strength
0.497
-
COVID-19 pneumonia in a large cohort of patients treated with biological and targeted synthetic antirheumatic drugs. Ann Rheum Dis. 2021 02; 80(2):e14.
Score: 0.221
-
Prognostic bioindicators in severe COVID-19 patients. Cytokine. 2021 05; 141:155455.
Score: 0.058
-
Portable Pocket-Sized Ultrasound Scanner for the Evaluation of Lung Involvement in Coronavirus Disease 2019 Patients. Ultrasound Med Biol. 2021 01; 47(1):19-24.
Score: 0.056
-
Serum KL-6 concentrations as a novel biomarker of severe COVID-19. J Med Virol. 2020 10; 92(10):2216-2220.
Score: 0.055
-
Peripheral lymphocyte subset monitoring in COVID-19 Italian patients. Minerva Med. 2021 06; 112(3):423-426.
Score: 0.055
-
Pleuroparenchymal fibroelastosis in patients affected by systemic sclerosis: What should the rheumatologist do? Medicine (Baltimore). 2019 Jun; 98(26):e16086.
Score: 0.052